|
Volumn 15, Issue 1, 1999, Pages 59-66
|
A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer-membrane-protein complex vaccine induces tumor protection in B16 murine melanoma
|
Author keywords
Cancer vaccines; Immunotherapy; Melanoma; Monosialogangliosidcs
|
Indexed keywords
BACTERIAL VACCINE;
BACTERIUM ANTIBODY;
CANCER ANTIBODY;
GANGLIOSIDE GM3;
IMMUNOGLOBULIN G;
MENINGOCOCCUS VACCINE;
OUTER MEMBRANE PROTEIN;
TUMOR ANTIGEN;
ANIMAL;
ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY;
ARTICLE;
C57BL MOUSE;
COMPARATIVE STUDY;
COMPLEMENT ACTIVATION;
ENZYME IMMUNOASSAY;
EXPERIMENTAL MELANOMA;
FEMALE;
IMMUNOLOGY;
MALE;
MOUSE;
VACCINATION;
ANIMALS;
ANTIBODIES, BACTERIAL;
ANTIBODIES, NEOPLASM;
ANTIBODY-DEPENDENT CELL CYTOTOXICITY;
ANTIGENS, NEOPLASM;
BACTERIAL OUTER MEMBRANE PROTEINS;
BACTERIAL VACCINES;
COMPLEMENT ACTIVATION;
FEMALE;
G(M3) GANGLIOSIDE;
IMMUNOENZYME TECHNIQUES;
IMMUNOGLOBULIN G;
MALE;
MELANOMA, EXPERIMENTAL;
MENINGOCOCCAL VACCINES;
MICE;
MICE, INBRED C57BL;
VACCINATION;
|
EID: 0033163316
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.15.1.59 Document Type: Article |
Times cited : (28)
|
References (4)
|